Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

496 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Divergent effect of bacillus Calmette-Guérin (BCG) vaccination on Mycobacterium tuberculosis infection in highly related macaque species: implications for primate models in tuberculosis vaccine research.
Langermans JA, Andersen P, van Soolingen D, Vervenne RA, Frost PA, van der Laan T, van Pinxteren LA, van den Hombergh J, Kroon S, Peekel I, Florquin S, Thomas AW. Langermans JA, et al. Among authors: van soolingen d, van pinxteren la, van der laan t, van den hombergh j. Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11497-502. doi: 10.1073/pnas.201404898. Epub 2001 Sep 18. Proc Natl Acad Sci U S A. 2001. PMID: 11562492 Free PMC article. Clinical Trial.
Molecular evidence to support a proposal to reserve the designation Mycobacterium avium subsp. avium for bird-type isolates and 'M. avium subsp. hominissuis' for the human/porcine type of M. avium.
Mijs W, de Haas P, Rossau R, Van der Laan T, Rigouts L, Portaels F, van Soolingen D. Mijs W, et al. Among authors: van soolingen d, van der laan t. Int J Syst Evol Microbiol. 2002 Sep;52(Pt 5):1505-1518. doi: 10.1099/00207713-52-5-1505. Int J Syst Evol Microbiol. 2002. PMID: 12361252
TB diagnosis in non-human primates: comparison of two interferon-gamma assays and the skin test for identification of Mycobacterium tuberculosis infection.
Vervenne RA, Jones SL, van Soolingen D, van der Laan T, Andersen P, Heidt PJ, Thomas AW, Langermans JA. Vervenne RA, et al. Among authors: van soolingen d, van der laan t. Vet Immunol Immunopathol. 2004 Jul;100(1-2):61-71. doi: 10.1016/j.vetimm.2004.03.003. Vet Immunol Immunopathol. 2004. PMID: 15182996
Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6.
Langermans JA, Doherty TM, Vervenne RA, van der Laan T, Lyashchenko K, Greenwald R, Agger EM, Aagaard C, Weiler H, van Soolingen D, Dalemans W, Thomas AW, Andersen P. Langermans JA, et al. Among authors: van soolingen d, van der laan t. Vaccine. 2005 Apr 15;23(21):2740-50. doi: 10.1016/j.vaccine.2004.11.051. Vaccine. 2005. PMID: 15780721
Antimycobacterial agents differ with respect to their bacteriostatic versus bactericidal activities in relation to time of exposure, mycobacterial growth phase, and their use in combination.
Bakker-Woudenberg IA, van Vianen W, van Soolingen D, Verbrugh HA, van Agtmael MA. Bakker-Woudenberg IA, et al. Among authors: van soolingen d, van agtmael ma, van vianen w. Antimicrob Agents Chemother. 2005 Jun;49(6):2387-98. doi: 10.1128/AAC.49.6.2387-2398.2005. Antimicrob Agents Chemother. 2005. PMID: 15917538 Free PMC article.
496 results